Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Duintjer Tebbens, Radboud J.
Hampton, Lee M.
Thompson, Kimberly M.
Funding for this research was provided by:
Center for Global Health (Contract 200-2015-M-63078)
Text and Data Mining valid from 2016-06-01
Version of Record valid from 2016-06-01
30 December 2015
4 May 2016
1 June 2016